MSF Scientific Days bring together researchers, practitioners, academics and patient representatives to catalyse improvements in the quality of care provided to patients and populations at risk.
By supporting research and innovation in our projects, MSF aims to improve outcomes, find efficiencies and create a culture of best practice, constantly improving the standards of care provided to our patients.
Call for abstracts 2021
MSF Scientific Days welcomes the submission of research and innovation projects from across MSF, as well as from external organisations with research directly applicable to, and connected with, MSF. It is also possible for applicants to showcase their research in poster/video form or as a demonstration. All applications, including for posters and demonstrations, are submitted via the same abstract submission process.
The abstract system is now open for submission to all Scientific Days.
First submission deadline: 13 January 2021. This is the deadline for MSF Scientific Days International.
The submission system for MSF Scientific Days 2021 will open twice this year. The first window is for submission to all events (MSF Scientific Days International, Europe, Asia, Latin America and Southern Africa). The second window is for MSF Scientific Days Asia, Latin America and Southern Africa ONLY.
If you wish your research or innovation to be considered for MSF Scientific Days International or Europe, it must be submitted in the first window (23 November 2020 – 13 January 2021). If you submit your work during window one there is no need to resubmit during window two as all work will be carried forward for consideration by the editorial committees of MSF Scientific Days Asia, Latin America and Southern Africa.
The second submission window will be open from 25 February – 29 March 2021.
If you require any further information about MSF Scientific Days please contact us.
The importance of addressing ethics in your research or innovation project
MSF Scientific Days seek to showcase research that has been carried out according to the highest possible ethical standards.Working in partnership with communities to preserve and enhance their wellbeing must be the overarching imperative of any research, which is why all MSF researchers should be familiar with the MSF research ethics framework. Independent ethical review by the MSF Ethics Review Board (ERB) is essential to achieving this aim, and therefore all research involving human subjects must be submitted to ethics review.
Research can be exempted from ERB review under certain conditions:
Analysis of routinely collected clinical data does not require ERB review if the medical directors take responsibility for addressing the ethics issues. The following criteria must be fulfilled to qualify for exemption from ERB review:
- Studies/articles are based on routinely-collected programme data.
- They are either descriptive/evaluative or targeted evaluations.
- Confidentiality is respected; no individual patient identifiers are revealed.
- Harm is minimal but acknowledged where relevant.
- Potential benefits to both the programme and the community are described. Since the goal is publication, the relevance to a wider audience is considered.
- Collaborative involvement and, if applicable, authorship from a local authority or partner (Ministry of Health, DHO, other NGO) is encouraged. If relevant and possible, consultation with a body representing the community is desirable.
- If the decision for exemption from review is taken by the medical directors, the responsibility to ensure that ethical requirements are met lies with MSF. This, however, does not exempt MSF from complying with regulatory requirements in the country where the data originated. In some countries, local ethical review may still be required.
Research involving human participants, including use of their data, requires approval by the MSF Ethics Review Board (ERB) and, similarly, innovation projects that constitute medical research (i.e. involving human participants or their data) should follow the research ethics review process. However, innovation projects can involve ethical risks and have consequences for populations even if human participants are not directly involved. Therefore the Project Sponsor (or whoever is responsible for oversight of the initiative) should consult the MSF innovation ethics framework to ensure that their project is ethically sound.
If you can answer ‘yes’ to any of the following questions, we suggest you seek advice on whether your project requires ethical evaluation:
- Does your project involve vulnerable participants such as children, disabled people, the elderly, prisoners, people in health or social care settings, addicts, or displaced persons – either contacted directly or via a gatekeeper (e.g. a service provider, care-giver, relative)?
- Does your project involve any risk to the participants’ health, or involve psychological stress, anxiety, physical pain or discomfort to the investigator and/or the participants?
- Does your project involve financial inducement offered to participants other than reasonable expenses and compensation for time?
- Does your project involve the collection of participants’ personal data other than gender, age and address; and have you ensured all reasonable steps are/will be taken to safeguard their anonymity?
- Does your project involve sensitive materials or topics that might be considered offensive, distressing, politically or socially sensitive, deeply personal or in breach of the law?
- Does your project have a detrimental impact on the environment, habitat, or species?
All of the presentations, slides and posters from MSF Scientific Days International (London) 2020 are now available in our online archive:
- View the Medical Research Day interactive agenda
- View the Innovation Day interactive agenda
- You can also read poems inspired by MSF Scientific Days 2020 by our resident conference poet, Mr Gee
The agenda at MSF Scientific Days International 2019 included sessions on ‘Taking Refuge in the City: The Humanitarian Response to Urban Crises’ and ‘Failing Interventions, Resistant Bugs’. All of the session videos and accompanying slides can also easily be accessed via the interactive online agenda.
As part of our commitment to catalyse improvements in best healthcare practice we make our research publicly available. Videos, slides, abstracts and posters from previous Scientific Days are available in our research archive